Back to Thymosin-alpha-1 research
thymosin-alpha-1 2026-04-03 PubMed

Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


thymosin-alpha-1 thymosin-alpha-1 acute-necrotising-pancreatitis ipn immune-enhancement rct critical-care
Source: pubmed:35713670 · Ingested Apr 3, 2026